MYX 6.13% $7.44 mayne pharma group limited

New Product Approvals, page-74

  1. 6,813 Posts.
    lightbulb Created with Sketch. 428
    Basically E4 should wipe out every other competitor
    direct or indirect if they really promote the benefits as highlighted here.
    USA market is pretty big.
    I think MYX will get it basically near cost price as Mithra already paid and will be paid in many other ways.
    Margins also will be big.
    I see finally 2 companies merging/takeover/share swap etc in 5 years time.
    Last edited by Chartsshout: 15/01/20
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$7.44
Change
0.430(6.13%)
Mkt cap ! $623.5M
Open High Low Value Volume
$7.01 $7.46 $6.99 $2.208M 303.5K

Buyers (Bids)

No. Vol. Price($)
8 545 $7.43
 

Sellers (Offers)

Price($) Vol. No.
$7.44 94 2
View Market Depth
Last trade - 14.44pm 03/05/2024 (20 minute delay) ?
Last
$7.45
  Change
0.430 ( 6.40 %)
Open High Low Volume
$7.00 $7.47 $7.00 37657
Last updated 15.03pm 03/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.